Diabetic Retinopathy Market By Type (Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR)), By Treatment (Anti-VEGF Therapy, Steroid Implants, Laser Photocoagulation, Vitrectomy), By Diagnosis (Fluorescein Angiography, Optical Coherence Tomography (OCT), Fundus Photography, Visual Acuity Testing), By End-user (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Research & Academic Institutes), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035.
Published Date: Mar 2025 | Report ID: MI2265 | 215 Pages
Report Coverage:
By Type
- Non-Proliferative Diabetic Retinopathy (NPDR)
- Proliferative Diabetic Retinopathy (PDR)
By Treatment
- Anti-VEGF Therapy
- Steroid Implants
- Laser Photocoagulation
- Vitrectomy
By Diagnosis
- Fluorescein Angiography
- Optical Coherence Tomography (OCT)
- Fundus Photography
- Visual Acuity Testing
End-user
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
- Research & Academic Institutes
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Novartis AG
- Regeneron Pharmaceuticals, Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- AbbVie
- Santen Pharmaceutical Co., Ltd.
- Ophthotech Corporation
- Kodiak Sciences Inc.
- Horizon Therapeutics
- Kowa Company, Ltd.
- Pfizer Inc.
- Valeant Pharmaceuticals International, Inc.
- Alimera Sciences, Inc.
- EyePoint Pharmaceuticals, Inc.
- Intrexon Corporation
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.